Aclaris therapeutics inc.

Major-Pharmaceuticals

ACRS


640 Lee Road
Wayne , PA 19087

Executive/
Director

Price

  • Last Close
  • $ 3.94
    $ +0.14 3.68 %
    Dec 6, 2024
  • 52-Week High/Low
  • $8 - $0.64
  • YTD
  • 275.2%

  • Trading Volume
  • 49,191
  • Market Cap Full
  • $ 279.1M
  • Shares Outstanding
  • 70.8M
    Oct 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -29.7% 9.9% -29% -18.9% -5% 270.3% 18.6% -48.6% 18.1%
Q2 - -2.5% -9.1% 19.9% -64.1% 4% -26.7% -19% 28.2% -3.2%
Q3 - 38.7% -4.8% -25.7% -53.8% 8% 2.5% 12.8% -33.9% -
Q4 143.8% 6% -6.6% -50.4% 70.1% 151.8% -19.2% 0.1% -83.8% -
J F M A M J J A S O N D
2024 10.5% 2.6% 4.2% -1.6% - - - - - - - -
2023 7.3% -26.3% -35.1% 9.9% -6.1% 24.2% -4.8% -24.2% -8.4% -27.3% -82.4% 20%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%1%-9%-70%-75%246%125%8%-93%275%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 0.65 0.48 -0.98 -0.91 -0.37 -0.57 -0.31 -0.42
Q2 - 0.62 0.56 -1.01 -1.21 -0.28 -0.34 -0.31 -0.42
Q3 5.11 0.50 0.63 -1.06 -1.34 -0.25 -0.35 -0.3 -0.41
Q4 0.28 0.49 0.80 -0.98 -0.45 -0.3 -0.34 -0.41 -
A 5.4 2.3 2.5 -4 -3.9 -1.2 -1.6 -1.3 -1.25

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 41.3 41.5 51.8 61.3 66.7
Jun 30.9 41.3 41.9 52.1 66.6 70.7
Sep 31 41.4 42.7 61.2 66.7 70.8
Dec 40.9 41.4 42.9 61.2 66.7 70.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - 7
Fixed Asset Turnover 1.9 0.2 0.9 0.6 2.5
Total Asset Turnover 0.1 - 0.1 - -
Leverage
Debt Ratio - - 0.2 - 0.2
Debt – Equity Ratio - - 0.3 - 0.1
Interest Coverage 30 -90 - -2.2 67.5
Equity multiplier 0.1 0.2 0.2 0.1 -